Skip to Main Content

Paper Details

Baroreflex activation therapy with the Barostimâ¿¢ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.
Eur J Heart Fail
19
2022
Author NameAffiliation
William T AbrahamThe Ohio State University
JoAnn LindenfeldVanderbilt Heart and Vascular Institute
Fred A WeaverKeck School of Medicine, University of Southern California
Marat FudimDuke University Medical Center
Marat FudimDuke Clinical Research Institute
  • 1 - 5

Datasets

Release 1.2